N-Acetyl Semax Amidate: Capped Termini Explained

N-acetyl Semax amidate is Semax with both ends chemically capped: an acetyl group on the N-terminal amine and an amide at the C-terminus. Capping termini is a standard way to protect short peptides from the enzymes that trim them from each end. For Semax the logic is clear from its known degradation pattern, but the published evidence on the capped forms is much thinner than online descriptions suggest.

For laboratory research use only. The compounds discussed are not approved for human or veterinary use and are not drugs, foods or cosmetics. This article summarises published research and is not medical advice.

Key points

Acetylation adds ~42 Da and removes the free N-terminal amine.
Amidation removes the C-terminal negative charge (−1 Da).
Semax degrades mainly from the N-terminus, which is what acetylation targets.
Acetylation changes copper(II) coordination and, with it, some in vitro behaviour.
No peer-reviewed potency or pharmacokinetic comparison with Semax was found.

The three forms

Form	Structure	Approx. mass	Termini
Semax	H-MEHFPGP-OH	813.9 g/mol	Free amine, free acid
N-acetyl Semax	Ac-MEHFPGP-OH	~855.9 g/mol	Capped amine, free acid
N-acetyl Semax amidate	Ac-MEHFPGP-NH₂	~854.9 g/mol	Capped amine, amide

Masses are derived from Semax’s PubChem value plus 42.0 for acetylation and −1.0 for amidation. Our Semax research peptide is the unmodified form; always check which form a certificate of analysis describes. Background on the parent peptide: what is Semax?

Why cap the N-terminus?

Using evenly tritium-labelled peptides, Zolotarev and colleagues showed that Semax incubated with nerve cells breaks down mainly to the pentapeptide HFPGP and the tripeptide PGP, that is, by removal of residues from the N-terminal end (Zolotarev et al., 2006). Aminopeptidases require a free N-terminal amine to act. Acetylating it removes that handle, which is the structural reason for expecting slower N-terminal trimming. C-terminal amidation addresses the opposite end, where carboxypeptidases act. Formulation reviews list chemical modification of this kind alongside pH and buffer optimisation among strategies for stabilising peptides (Nugrahadi et al., 2023).

What acetylation demonstrably changes

The clearest published comparison concerns metal binding. Semax coordinates Cu(II) using its N-terminal amine, backbone amide nitrogens and the histidine imidazole. When the amine is acetylated, that anchor is gone, and at physiological pH the main complex formed by Ac-Semax is a different species. Magrì and colleagues reported that this altered copper coordination was accompanied by changes in biological properties measured in vitro (Magrì et al., 2016).

Property	Semax	N-acetyl Semax
Free N-terminal amine	Yes	No
Main aminopeptidase route	Available	Blocked at the terminus
Cu(II) coordination at pH 7.4	Amine-anchored complex	Different main species
Net charge	Includes N-terminal positive charge	One fewer positive charge

For experiments, this means the two forms are not interchangeable when copper or zinc is present in the buffer or medium.

What is not established

Statements that the capped form is a specific multiple more potent, or lasts a particular number of times longer, are common in product descriptions. We found no peer-reviewed pharmacokinetic or dose–response comparison between Semax and its acetylated or amidated versions. Two further caveats are worth noting:

Fragments may matter. PGP, one of Semax’s breakdown products, activated neurotrophin and receptor transcription on its own in a rat ischemia model (Dmitrieva et al., 2010). If some activity depends on fragments, slowing degradation does not necessarily increase effect.
Different experiments. Published work on the unmodified peptide cannot simply be transferred to the capped forms, since the two differ in charge and metal binding as well as stability.

Identity testing

Because supplier naming is inconsistent, mass spectrometry is the practical way to confirm which form is in a vial. The ~41 Da difference between Semax and the capped forms is easy to resolve, and a +16 Da satellite indicates methionine oxidation in either form. A Belgian control laboratory developed an LC-MS/MS method after finding Semax and Selank in seized preparations, illustrating that these peptides are well behaved analytically (Vanhee et al., 2020).

Handling in the lab

Store powder at −20 °C, sealed and dark; keep solutions at 2–8 °C.
Both forms contain methionine, so limit air and light exposure.
Avoid adventitious copper and zinc, and keep chelator use consistent across compared conditions.
Water-soluble; see how to reconstitute peptides and the peptide reconstitution calculator.

Open questions

How do the half-lives of Semax and its capped forms compare in the same assay?
Does blocking N-terminal degradation reduce formation of active fragments such as PGP, and does that change net activity?
Do the capped forms reproduce the neurotrophin findings reported for unmodified Semax?

Related research

Frequently asked questions

What is N-acetyl Semax amidate?

It is Semax (Met-Glu-His-Phe-Pro-Gly-Pro) with an acetyl group on the N-terminal amine and an amide in place of the C-terminal acid. Both are common ways to protect short peptides from exopeptidases.

Is NA-Semax the same as N-acetyl Semax?

Yes. ‘NA-Semax’ is shorthand for N-acetyl Semax; ‘NA-Semax-NH2’ or ‘amidate’ denotes the version that is also C-terminally amidated.

How do the masses differ?

Relative to Semax at 813.9 g/mol, acetylation adds about 42 Da and amidation subtracts about 1 Da, so N-acetyl Semax amidate is about 854.9 g/mol.

Does capping change how Semax binds copper?

Yes. Semax anchors Cu(II) through its free N-terminal amine. With that amine acetylated, a different main copper complex forms at physiological pH, and some in vitro properties change with it.

Is the acetylated form more potent than Semax?

We did not find peer-reviewed potency or pharmacokinetic comparisons. The chemical rationale for slower degradation is sound, but specific multipliers quoted online are not supported by data we could verify.

References

Magrì A, et al. Influence of the N-terminus acetylation of Semax, a synthetic analog of ACTH(4-10), on copper(II) and zinc(II) coordination and biological properties. J Inorg Biochem. 2016. PMID: 27586814 https://pubmed.ncbi.nlm.nih.gov/27586814/
Zolotarev IuA, et al. [Evenly tritium-labeled peptides and their in vivo and in vitro biodegradation]. Bioorg Khim. 2006. PMID: 16637290 https://pubmed.ncbi.nlm.nih.gov/16637290/
Dmitrieva VG, et al. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell Mol Neurobiol. 2010. PMID: 19633950 https://pubmed.ncbi.nlm.nih.gov/19633950/
Nugrahadi PP, et al. Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review. Pharmaceutics. 2023. PMID: 36986796 https://pubmed.ncbi.nlm.nih.gov/36986796/
Vanhee C, et al. The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind. Drug Test Anal. 2020. PMID: 31667971 https://pubmed.ncbi.nlm.nih.gov/31667971/
PubChem Compound Summary for CID 9811102, Semax. National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/9811102